title: Bivalirudin versus heparin for peripheral vascular intervention: You get what you pay for….
authors.affiliation: Division of Cardiology, The Cardiac Catheterization Laboratory, Tufts Medical Center, Boston, Massachusetts.
authors.forename: Carey
authors.identifier: 0000-0002-1902-1739
authors.initials: C
authors.lastname: Kimmelstiel
authors.affiliation: Science and Strategy Consulting Group, Basking Ridge, New Jersey.
authors.forename: Efthymios N
authors.initials: EN
authors.lastname: Deliargyris
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006629:Hirudins; D006801:Humans; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin